Rare cutaneous manifestation of COVID-19 infection and Pfizer-BioNTech COVID-19 vaccine with a unique pattern similarity.
COVID-19
cutaneous
dermatological
lesions
maculopapular
vaccine
Journal
Future virology
ISSN: 1746-0794
Titre abrégé: Future Virol
Pays: England
ID NLM: 101278124
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
received:
05
06
2021
accepted:
06
10
2021
entrez:
28
10
2021
pubmed:
29
10
2021
medline:
29
10
2021
Statut:
ppublish
Résumé
In December 2019, a new emerging virus causing mild-to-severe pneumonia was detected in China. The virus was described as a variant of SARS-CoV and was called SARS-CoV-2, then declared a pandemic by the WHO on 11 March 2020. Millions of people contracted the virus and presented with a symptomatology of variable severity, including upper respiratory tract symptoms, systemic symptoms and diarrhea. We herein report a rare skin presentation in a 33-year-old female that occurred both during COVID-19 infection and after receiving the first dose of COVID-19 vaccine.
Identifiants
pubmed: 34707681
doi: 10.2217/fvl-2021-0129
pmc: PMC8529702
doi:
Types de publication
Case Reports
Langues
eng
Informations de copyright
© 2021 Future Medicine Ltd.
Références
Clin Exp Vaccine Res. 2014 Jan;3(1):50-7
pubmed: 24427763
Int Arch Allergy Immunol. 2019;178(2):167-176
pubmed: 30448840
J Med Case Rep. 2020 Nov 9;14(1):216
pubmed: 33168054
Br J Dermatol. 2020 Sep;183(3):431-442
pubmed: 32479680
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e686-e689
pubmed: 32589293
Immunol Allergy Clin North Am. 2014 Aug;34(3):597-613, ix
pubmed: 25017679
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
World J Clin Cases. 2021 Jul 16;9(20):5744-5751
pubmed: 34307634
Dermatol Ther. 2020 Nov;33(6):e14170
pubmed: 32779280
J Allergy Clin Immunol. 2018 Feb;141(2):463-472
pubmed: 29413255
J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e755-e757
pubmed: 32495368
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):2499-2504
pubmed: 32585074